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Purpose: Interleukin (IL)-21 has recently been shown to play a vital role in the development of many autoimmune diseases.
Our study is designed to investigate the alteration and possible function of IL-21 in the development of an experimental
autoimmune uveitis (EAU) model.
Methods: EAU was induced in B10.RIII mice by subcutaneous injection of interphotoreceptor retinoid-binding protein
(IRBP) 161–180 emulsified with complete Freund’s adjuvant (CFA) and evaluated by clinical and histopathologic
observation. IL-21 and IL-21R mRNA expressions in cells of draining lymph node (DLN) and spleen in EAU and control
mice were determined by reverse transcription-PCR. The frequencies of interleukin-21 receptor positive cells were also
examined using flow cytometry. IL-17 levels in the supernatant of the cell culture upon IL-21 stimulation were assayed
by enzyme-linked immunosorbent assay.
Results: Results showed that EAU was successfully induced by IRBP161–180. Expression of IL-21 mRNA was
significantly increased in cells of DLN and spleen in EAU compared with recovery phase mice and normal controls.
IL-21R was also found upregulated in DLN and spleen cells of EAU mice by reverse transcription-PCR and flow cytometry.
Cells in EAU cultured with IL-21 combined with transforming growth factor-β induced increased production of IL-17.
Conclusion: The findings revealed that increased IL-21 and IL-21R expression may be involved in the development of
EAU, possibly by promoting IL-17 secretion.
Human uveitis is a group of ocular inflammatory
disorders that affects the uvea, retina, vessels, and vitreous.
Uveitis and its associated complications cause the progressive
destruction of the eye and eventually result in blindness.
Experimental autoimmune uveitis (EAU) is a well-established
animal model for the human disease [1]. T helper (Th)1 cell-
mediated response was considered in the early years, to play
a critical role in the pathogenesis of uveitis [2]. However,
recent studies have demonstrated that interferon (IFN)-γ is not
the only key cytokine responsible. Interleukin (IL)-12 has
protective effects in the development of diseases in the EAU
model [3,4], while IL-17-producing CD4+ T cells (Th17 cells,
distinct from classic Th1 and Th2 cells) exerts more
pronounced functions in autoimmune diseases [5-7].
Upregulation of the IL-17–IL-23 pathway has also been
reported to play an important role in the pathogenesis of
human autoimmune diseases, but its precise mechanisms in
autoimmune uveitis remain unclear.
IL-21 is a novel pro-inflammatory cytokine that was
recently found to contribute to immune responses in the Th17
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pathways. It was first identified in 2000 as a new member of
the type I four-α-helical-bundle cytokine family; its receptor
shares the common γ chain and signals via the Janus kinase
(JAK)/ Signal Transducers and Activators of Transcription
(STAT) pathway [8,9]. In addition, IL-21 has been shown to
be mainly produced by activated CD4+ T cells, but its receptor
has been detected on several different cell types. Researchers
have found that IL-21 has broad effects on both innate and
adaptive immunity; it induces the proliferation and
differentiation of T and B lymphoid cells and increases the
activity of CD8+ T and natural killer cells [10,11]. Recently
IL-21 has been characterized as being closely related to Th17
cells; it promotes the differentiation of Th17 cells and
augments IL-17 production in vitro [12,13]. The pro-
inflammatory functions of IL-21 are also associated with
many autoimmune disease models, including experimental
autoimmune encephalomayelitis, adjuvant-induced arthritis
and experimental colitis [12,14,15]. However, whether IL-21
is involved in the development of uveitis, a typical
autoimmune disease, and whether it can regulate IL-17
production in EAU, are still unknown.
This study was, therefore, designed to investigate the
alteration and possible function of IL-21 in the development
of the EAU model. Our results showed that the expression of
IL-21 was markedly increased in both splenocytes and
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2938draining lymph node (DLN) cells of EAU mice compared to
that in the normal controls and the recovery phase. The
expression of the IL-21 receptor (IL-21R) was also found
significantly elevated in EAU mice in both mRNA and protein
levels. Recombinant IL-21 could promote the increase in
IL-17 production by splenocytes and DLN cells of EAU mice.
in vitro These data suggest that upregulated IL-21 production
may play an active role in the development of inflammation
in EAU mice.
METHODS
Mice: B10.RIII mice were purchased from the Jackson
Laboratory (Bar Harbor, ME). Mice were housed in a specific
pathogen-free facility at the animal center. Animal
experiments were performed at the age of 6–8 weeks
according to the ARVO statement for the Use of Animals in
Ophthalmic and Vision Research. All animal procedures were
approved by the institution’s animal care board.
Experimental autoimmune uveitis induction and scoring:
Human interphotoreceptor retinoid-binding protein (IRBP)
peptide 161–180 (SGIPYIISYLHPGNTILHVD) was
synthesized by the Shanghai Shenggong company (Shanghai,
China). Mice were immunized with a subcutaneous injection
of human IRBP peptide 161–180 (50 μg/mouse), emulsified
(1:1, vol/vol) with complete Freund’s adjuvant (CFA; Sigma-
Aldrich, St. Louis, MO). Pertussis toxin (Sigma-Aldrich),
1 μg in 0.1 ml, was concurrently injected intraperitoneally.
Mice were examined by slit lamp and direct funduscopy for
clinical signs. For histopathologic evaluation, eyes were
enuculated, fixed in 10% phosphate-buffered formaldehyde,
dehydrated, and embedded in methacrylate. Then 5-µm
sections were cut through the pupillary–optic nerve plane and
stained with hematoxylin and eosin (H&E; Guangzhou,
China). Disease scores were evaluated on the extent of
inflammation and tissue damage by histopathology, as
described [16]. Briefly, retinal perivascular infiltration and
monocytic infiltration in the vitreous were scored as 1;
granuloma formation, the presence of occluded retinal
vasculitis, photoreceptor folds, serous detachment and loss of
photoreceptor were scored as 2; formation of Dalen-Fuchs
nodules, and development of subretinal neovascularization
were scored as 3 and 4, according to the number and the size
of the lesions. Mice (Week 5-6 or more after immunization)
showed no inflammation by clinic and histopathological
observation were considered as mice of recovery phase. Mice
that were immunized with only CFA were used as controls.
Cell isolation and culture: Lymphocytes were harvested from
the spleen and DLN, using Ficoll-Hypaque density gradient
centrifugation. Cells were resuspended at a density of 2×106
cells/ml in RPMI 1640 medium (Gibco, Grand Island, NY)
containing L-glutamine (2 mM), penicillin/streptomycin (100
U/ml), and 10% fetal calf serum. For the cytokine assay cells
were cultured with or without recombinant mouse
interleukin-21 (rmIL-21; 100 ng/ml) and recombinant
transforming growth factor-β (rTGF-β; 5 ng/ml; both from
R&D Systems, Minneapolis, MN) for 72 h at 37 °C, 100%
humidity, and 5% CO2.
Reverse transcription polymerase chain reaction: Total RNA
was extracted from the splenocytes and DLN cells, using the
RNAprep Cell kit (Tiangen Biotech, Beijing, China),
according to the manufacturer’s instructions. Briefly, pellet of
5×106 cells was mixed with 350 μl lysate, transferred into a
filtration column, centrifuged 12,000 rpm for 30 s. Then the
pellet was washed with 70% ethanol, deproteinization water
in an absorption column. The absorption column was
resuspended with 50 μl RNAase-free water and centrifuged
12,000 rpm for 2 min. Total RNA was collected in a RNAase-
free tube. Reverse transcription of RNA into cDNA was
performed using the Superscript III Reverse Transcriptase
system (Invitrogen). The specific primers used for β-actin,
IL-21, and IL-21R used in this study were: β-actin sense: 5′-
GTC CCT CAC CCT CCC AAA AG-3′, antisense: 5′-GCT
GCC TCA ACA CCT CAA CCC-3′. IL-21 sense: 5′-TCA
TCA TTG ACC TCG TGG CCC-3′, antisense: 5′-ATC GTA
CTT CTC CAC TTG CAA TCC C-3′, IL-21R sense: 5′-CTC
CCC CCT TGA ACG TGA CT-3′, antisense: 5′-TTG CCC
CTC AGC ACG TAG TT-3′. The mRNA expression levels
of each sample were normalized to the levels of β-actin. A
total amount of 5 μl PCR product of each sample was
electrophoresed in the 2% agarose gels. The density of bands
was quantified by densitometry and analyzed with Genetools
software (Synoptics Ltd, Cambridge, UK).
Flow cytometry: The isolated cells were stained with anti-
CD3, anti-CD4, anti-CD8, and anti-IL-21R antibodies
(eBioscience, SanDiego, CA) for 0.5 h for the analysis of
surface markers. Cells were then washed three times and
suspended in PBS. fluorescence-activated cell sorting (FACS)
analysis was performed using FACS Calibur and CellQuest
software (BD Biosciences, Shanghai, China ).
Cytokines in enzyme-linked immunosorbent assay:
Supernatants were collected from cell cultures with different
stimulation, as mentioned above. IL-17 was measured using
the mouse IL-17 DuoSet enzyme-linked immunosorbent
assay (ELISA) development kit (R&D Systems), with a
detection limit of 5.6 pg/ml.
Statistics: The data were analyzed using SPSS 10.0 (SPSS,
Inc. Chicago, IL). The independent Student t-test was used to
assess differences between groups. Results were expressed as
mean±standard deviation, and p<0.05 was considered
significant.
RESULTS
Induction of the experimental autoimmune uveitis model: The
EAU model was induced by immunization of IRBP peptide
161–180 and evaluated by clinical observation and H&E
staining of the eye section. Flare and cells in the anterior
chamber, and vasculitis and choroiretinal lesions in the fundus
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2939were observed in the EAU mice. Histopathologic examination
showed inflammatory cell infiltration of the ciliary body,
choroid, vitreous and retina, vasculitis, granuloma formation,
retinal folding, detachment, and photoreceptor damage
(Figure 1B). There were no inflammatory signs observed by
clinical and histopathologic evaluation of mice during the
recovery phase (5–6 weeks after immunization). Control mice
(immunized with CFA only) showed no inflammation
clinically or histopathologically (Figure 1A).
Interleukin-21 expression is increased in splenocytes and
draining lymph node cells of experimental autoimmune uveitis
mice: IL-21 mRNAs in splenocytes and DLN cells of EAU
mice, recovery phase mice, and control mice were extracted
and measured using reverse transcriptase (RT)-PCR. IL-21
levels were presented by the intensity ratio of the IL-21 mRNA
band divided by β-actin mRNA band. Results showed that
mRNA expressions of IL-21 were significantly increased in
DLN cells of EAU mice (n=6) compared with recovery phase
mice (n=6, p=0.01) and normal controls (n=6, p=0.005; Figure
2A,C). IL-21 levels in the splenocytes of EAU mice (n=6)
were also markedly higher than that of recovery phase mice
(n=6, p=0.014) and normal controls (n=6, p=0.007; Figure
2B,C).
Interleukin-21 receptor expression is elevated in splenocytes
and draining lymph node cells of experimental autoimmune
uveitis mice: The expressions of IL-21R (IL-21R) in
splenocytes and DLN cells were detected by RT-PCR.
Significantly increased IL-21R expressions were found in
DLN cells of EAU mice compared with recovery phase mice
(p=0.001) and normal controls (p<0.001; Figure 3A,C). The
results also showed that IL-21 expressions were markedly
elevated in the splenocytes of EAU mice (p=0.04 compared
to recovery mice [p=0.018] and normal controls; Figure
3B,C).
We further investigated the expressions of IL-21R at the
single cell level using the method of flow cytometry. As
Figure 2. Reverse transcription-PCR analysis of interleukin-21 in the
cells of spleen and draining lymph node in experimental autoimmune
uveitis, recovery phase and control mice. mRNA of IL-21 in
splenocytes and draining lymph node (DLN) cells of EAU, recovery
phase mice, and control mice were extracted and measured through
RT–PCR. A: IL-21 mRNA of DLN cells in EAU, recovery phase
mice, and control mice. B: IL-21 mRNA of spleen cells in EAU,
recovery phase mice, and control mice. C: The relative IL-21 mRNA
levels were determined as the ratio of the IL-21 PCR product over
the β-actin product. Data are presented as mean±standard deviation;
n=6 per group.
Figure 1. Histopathologic features of the eyes of experimental autoimmune uveitis (EAU) mice. Eyes were enucleated from EAU and complete
Freund’s adjuvant (CFA) control mice on day 14 after immunization. Sections (5 µm) were cut through the pupillary–optic nerve plane and
stained with hematoxylin and eosin. A: Eye of CFA controls. The retina layers are well ordered and preserved. B: Eye of EAU mice. The
normal structure of the retina is disorganized. Inflammatory cells infiltrate the ciliary body, choroid, vitreous and retina. Vasculitis, granuloma
formation, and retinal folding are visible, and the photoreceptor layer is damaged. The scale bar=50 µm.
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2940showed in Figure 4, IL-21R expressions were significantly
increased in both CD4+ and CD8+ T cells in DLN of EAU mice
compared with that of normal controls (p<0.001 in CD4+T
cells; p=0.002 in CD8+T cells). A similar result was observed
in the splenocytes. IL-21R expressions in the splenocytes
were prominently higher in EAU mice than in control mice
(p<0.001 in CD4+T cells; p<0.001 in CD8+T cells).
Recombinant interleukin-21 combined with transforming
growth factor-β increases interleukin-17 secretion in
experimental autoimmune uveitis: The previous results
suggested that IL-21 might be involved in the development of
the immune reaction in EAU. Therefore, we further
investigated whether IL-21 could influence the production of
IL-17, a vital inflammatory cytokine in the pathogenesis of
uveitis. Cells were cultured with a stimulation of recombinant
IL-21 combined with transforming growth factor (TGF)-β.
Production of IL-17 in the supernatant was detected by
ELISA. A markedly higher concentration of IL-17 in the
supernatant of the cell culture was found in EAU mice
compared to normal controls without any stimulation
(p<0.001 in both DLN and spleen; Figure 5A). Stimulation of
recombinant IL-21 significantly upregulated IL-17 secretion
in DLN cells of EAU mice (p<0.001; Figure 5B). IL-17
production was also significantly increased in the supernatant
of the DLN cell cultures stimulated with IL-21 combined with
TGF-β compared to only TGF-β stimulation (p<0.001; Figure
5B). Similar to DLN cells, the concentration of IL-17 in the
Figure 3. Reverse transcription-PCR analysis of interleukin-21
receptor in the cells of spleen and draining lymph node in
experimental autoimmune uveitis, recovery phase and control mice.
mRNA of IL-21R in splenocytes and draining lymph node (DLN)
cells of EAU, recovery phase mice, and control mice were extracted
and measured through RT–PCR. A: IL-21R mRNA of DLN cells in
EAU, recovery phase mice, and control mice. B: IL-21R mRNA of
spleen cells in EAU, recovery phase mice, and control mice. C: The
relative IL-21 mRNA levels were determined as the ratio of the
IL-21 PCR product over the β-actin product. Data are presented as
mean±standard deviation; n=6 per group.
cell culturesof splenocytes was significantly elevated after
stimulation of IL-21 (p=0.002) or combined with TGF-β
(p<0.001).
DISCUSSION
Uveitis is considered a typical T-cell mediated, organ-
specific, autoimmune disease, but its etiology and pathology
are still elusive [17]. In this study, we explored the
involvement of IL-21 in the pathogenesis of EAU, given that
IL-21 acts as an essential cytokine in immune responses and
plays important roles in many autoimmune diseases [18]. Our
results showed that the expression of IL-21 and IL-21R were
significantly higher in both splenocytes and DLN cells of
EAU mice compared with those in recovery phase mice and
controls. In vitro recombinant mouse IL-21 combined with or
without TGF-β could induce markedly increased IL-17
secretion in cell cultures of splenocytes and DLN cells of EAU
mice. These results suggest that IL-21 may be actively
involved in promoting the development of EAU.
Figure 4. The percentage of interleukin-21 receptor positive cells
from draining lymph node of experimental autoimmune uveitis and
control mice. The isolated DLN cells were stained with anti-CD4,
anti-CD8, and anti-IL-21R Ab for 0.5 h for the analysis of surface
markers. A: Dot plots of IL-21R+ cells in CD4+ and CD8+ cells of
EAU and control mice. Data shown are representative of six
independent experiments. B: Percentages of IL-21R+ cells in CD4+
T cells of EAU and control mice. C: Percentages of IL-21R+ cells in
CD8+ T cells. Data are presented as mean±standard deviation; n=6
per group.
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2941It has been demonstrated recently that IL-21 plays a
pivotal role in either initial or acquired immunity and is
closely associated with several autoimmune diseases, such as
multiple sclerosis and inflammatory bowl disease [12,14].
Administration of IL-21 promoted the inflammatory influx
and increased the severity of disease, and IL-21-deficient mice
showed markedly reduced disease score [13]. To further
investigate its function, we analyzed the role of IL-21 in EAU,
a typical T-cell-mediated autoimmune disease. First we
examined the expression of IL-21 in EAU mice and controls.
IL-21 mRNA levels in the DLN cells of EAU mice were
upregulated compared with recovery phase mice and controls.
We found a similar augmentation in the splenocytes of EAU.
These results indicate that the increased expression of IL-21
is associated with the development of EAU.
Figure 5. Interleukin-17 production in the culture supernatant of
experimental autoimmune uveitis and control mice. Cells from DLN
and spleen were cultured with or without stimulation. The
concentration of IL-17 in the supernatant was detected by ELISA.
A: IL-17 production by DLN and spleen cells in EAU and control
mice without stimulation. B: IL-17 production by DLN and spleen
cells after IL-21 combined with or without TGF-β stimulation. Data
are presented as mean±standard deviation; n=6 per group.
IL-21 executes its function through its receptor, which is
expressed by several types of immune cells. A higher
expression of IL-21R was also found in several autoimmune
disorders, and blockade of the IL-21R pathway resulted in
amelioration of the disease [19,20]. Therefore, we examined
whether IL-21R expressions in DLN and spleen cells of EAU
mice are also elevated. Results showed that IL-21R
expressions are significantly increased in both DLN and
spleen cells of EAU mice at the mRNA level compared to
recovery phase mice and controls. Elevated IL-21R
expression was also detected in EAU at the protein level by
flow cytometry analysis. There was a markedly higher IL-21R
expression in either CD4+ or CD8+ cells of EAU mice
compared with controls, and we obtained similar results for
both DLN and spleen cells. Other studies have shown that
IL-21R is upregulated on T cells upon activation [9]. Thus,
the results that CD4+ and CD8+ T cells express high levels of
IL-21R suggest that these cells may be the potential target
cells of IL-21 in EAU mice.
The mechanism of IL-21 function and its specific role in
Th1/Th2/Th17 cell differentiation and related response
remains to be clarified. Recent studies have shown that IL-21
is highly expressed by Th17 cells and could promote the
differentiation of Th17 cells in vitro and in vivo [21-23]. In
view of the crucial effects of IL-17 in the pathogenesis of
autoimmune diseases, including uveitis [24], we investigated
the influence of IL-21 on IL-17 production in the EAU model.
IL-17 was first found significantly increased in the DLN and
spleen cells of EAU mice compared to controls without
stimulation. This suggests that IL-17 plays an important role
in the development of autoimmune uveitis. The effects of
IL-21 on IL-17 production were observed using methods
similar to those used by other authors [12,13]. Our results
showed that IL-21 would induce IL-17 secretion in the DLN
and spleen cells of EAU mice. IL-21 combined with TGF-β
stimulation promoted a significantly increased IL-21
production in the EAU cells.
The theories concerning the role of IL-21 in Th1, Th2,
and Th17 responses are still controversial. Studies have
demonstrated that IL-21 is essential for the differentiation of
Th17 cells and plays a crucial role in the pathogenesis of
several autoimmune diseases [12,13,21]. There is also a report
that IL-21 is not essential for Th17 expansion in EAE models
[25]. This discrepancy might be because of the different model
and genetic backgrounds of the mouse lines used for the two
studies. A recent study has also shown that IL-21 production
is not restricted to CD4+ T cells; natural killer T cells are also
potent producers of IL-21 [26]. Studies of the detailed
mechanisms of IL-21 function in EAU, including the cellular
source of IL-21, will be performed in the near future.
Inhibition experiments using anti-IL-21 antibody or IL-21
knockout mice should also be done to further identify the
effects of IL-21 in EAU.
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2942In  summary,  our  study  showed  that  increased  IL-21
production and elevated IL-21R expression may be associated
with the development of autoimmune uveitis in mice. Our
results showed that IL-21 or combined with TGF-β would
induce increased IL-17 production. With the suggestion that
the  IL-21–IL-21R  pathway  may  be  involved  in  the
pathogenesis of autoimmune uveitis, we propose a possible
therapeutic  approach  for  autoimmune  uveitis  through  the
manipulation of IL-21 secretion.
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